Editorial: Pharmaceutically active micropollutants - how serious is the problem and is there a microbial way out?
作者信息
Singh Aditi, Lalung Japareng, Ivshina Irina, Kostova Irena
机构信息
Amity Institute of Biotechnology, Amity University Uttar Pradesh, Lucknow, India.
School of Industrial Technology, University Sains Malaysia, George Town, Malaysia.
出版信息
Front Microbiol. 2024 Aug 30;15:1466334. doi: 10.3389/fmicb.2024.1466334. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Pharmaceutically active micropollutants - how serious is the problem and is there a microbial way out?社论：具有药物活性的微污染物——问题有多严重，是否有微生物解决之道？
Front Microbiol. 2024 Aug 30;15:1466334. doi: 10.3389/fmicb.2024.1466334. eCollection 2024.
2
The potential of fungi in the bioremediation of pharmaceutically active compounds: a comprehensive review.真菌在生物修复药物活性化合物中的潜力：全面综述
Front Microbiol. 2023 Jul 12;14:1207792. doi: 10.3389/fmicb.2023.1207792. eCollection 2023.
3
Biodegradability, environmental risk assessment and ecological footprint in wastewater technologies for pharmaceutically active compounds removal.可生物降解性、环境风险评估和废水中药物活性化合物去除技术的生态足迹。
Bioresour Technol. 2022 Jan;343:126150. doi: 10.1016/j.biortech.2021.126150. Epub 2021 Oct 19.
4
Microbial community response during the treatment of pharmaceutically active compounds (PhACs) in constructed wetland mesocosms.人工湿地中试系统处理药物活性化合物（PhACs）过程中的微生物群落响应。
Chemosphere. 2017 Nov;186:823-831. doi: 10.1016/j.chemosphere.2017.08.064. Epub 2017 Aug 14.
5
Pharmaceutically active compounds (PhACs) in surface sediments of the Jiaozhou Bay, north China.中国北方胶州湾表层沉积物中的药物活性化合物（PhACs）。
Environ Pollut. 2020 Nov;266(Pt 3):115245. doi: 10.1016/j.envpol.2020.115245. Epub 2020 Jul 14.
6
Role of biodegradation in the removal of pharmaceutically active compounds with different bulk organic matter characteristics through managed aquifer recharge: batch and column studies.通过管理型含水层补给去除具有不同大宗有机物特性的药物活性化合物中的生物降解作用：批量和柱研究。
Water Res. 2011 Oct 15;45(16):4722-36. doi: 10.1016/j.watres.2011.05.043. Epub 2011 Jun 7.
7
Ecotoxicological study of seven pharmaceutically active compounds: Mixture effects and environmental risk assessment.七种药物活性化合物的生态毒理学研究：混合物效应及环境风险评估。
Aquat Toxicol. 2024 Oct;275:107068. doi: 10.1016/j.aquatox.2024.107068. Epub 2024 Aug 30.
8
In-situ chemical attenuation of pharmaceutically active compounds using CaO: Influencing factors, mechanistic modeling, and cooperative inactivation of water-borne microbial pathogens.利用氧化钙原位化学衰减药物活性化合物：影响因素、机理建模和水传播微生物病原体的协同灭活。
Environ Res. 2022 Sep;212(Pt D):113531. doi: 10.1016/j.envres.2022.113531. Epub 2022 May 22.
9
Biocatalytic remediation of pharmaceutically active micropollutants for environmental sustainability.生物催化修复环境可持续性中的药物活性微量污染物。
Environ Pollut. 2022 Jan 15;293:118582. doi: 10.1016/j.envpol.2021.118582. Epub 2021 Nov 29.
10
Risk assessment of pharmaceutically active compounds (PhACs) in the Klang River estuary, Malaysia.马来西亚巴生河口制药活性化合物（PhACs）的风险评估。
Environ Geochem Health. 2019 Feb;41(1):211-223. doi: 10.1007/s10653-018-0157-1. Epub 2018 Jul 26.
引用本文的文献
1
Adaptive responses of IEGM 1277 to the action of meloxicam and its efficient biodegradation.IEGM 1277对美洛昔康作用的适应性反应及其高效生物降解
Front Bioeng Biotechnol. 2025 Jul 23;13:1603975. doi: 10.3389/fbioe.2025.1603975. eCollection 2025.
2
Pharmaceutically active micropollutants: origin, hazards and removal.具有药物活性的微污染物：来源、危害及去除
Front Microbiol. 2024 Feb 14;15:1339469. doi: 10.3389/fmicb.2024.1339469. eCollection 2024.
本文引用的文献
1
Accumulation of antibiotics in the environment: Have appropriate measures been taken to protect Canadian human and ecological health?抗生素在环境中的积累：是否采取了适当措施来保护加拿大的人类和生态健康？
Ecotoxicol Environ Saf. 2024 Jul 15;280:116513. doi: 10.1016/j.ecoenv.2024.116513. Epub 2024 May 30.
2
Occurrence, fate, and potential risk of pharmaceutical pollutants in agriculture: Challenges and environmentally friendly solutions.医药污染物在农业中的产生、归宿和潜在风险：挑战与环保解决方案。
Sci Total Environ. 2023 Nov 15;899:165323. doi: 10.1016/j.scitotenv.2023.165323. Epub 2023 Jul 7.
3
Global antimicrobial-resistance drivers: an ecological country-level study at the human-animal interface.全球抗菌药物耐药性驱动因素：在人与动物接触界面的生态国家级研究。
Lancet Planet Health. 2023 Apr;7(4):e291-e303. doi: 10.1016/S2542-5196(23)00026-8.
4
Presence Of Non-Steroidal Anti-Inflammatories In Brazilian Semiarid Waters.巴西半干旱水域中存在非甾体抗炎药。
Water Air Soil Pollut. 2023;234(4):225. doi: 10.1007/s11270-023-06239-2. Epub 2023 Mar 24.
5
Removal of Non-Steroidal Anti-Inflammatory Drugs from Drinking Water Sources by GO-SWCNT Buckypapers.GO-SWCNT 碳纳米纸去除饮用水源中的非甾体抗炎药。
Molecules. 2022 Nov 8;27(22):7674. doi: 10.3390/molecules27227674.
6
strains as a good biotool for neutralizing pharmaceutical pollutants and obtaining therapeutically valuable products: Through the past into the future.菌株作为一种用于中和药物污染物和获取具有治疗价值产品的良好生物工具：从过去到未来。
Front Microbiol. 2022 Sep 29;13:967127. doi: 10.3389/fmicb.2022.967127. eCollection 2022.
7
Genetically engineered microorganisms for environmental remediation.用于环境修复的基因工程微生物。
Chemosphere. 2023 Jan;310:136751. doi: 10.1016/j.chemosphere.2022.136751. Epub 2022 Oct 6.
8
QuEChERS-based analysis and ecotoxicological risk of select antibiotics in dumpsite leachates, hospital wastewater and effluent receiving water in Ibadan, Nigeria.基于 QuEChERS 的尼日利亚伊巴丹垃圾渗滤液、医院废水和污水接收水中选择抗生素的分析及生态毒理学风险评估。
J Environ Sci Health A Tox Hazard Subst Environ Eng. 2022;57(8):709-722. doi: 10.1080/10934529.2022.2104064. Epub 2022 Jul 26.
9
Isolation and identification of acetaminophen degrading strain sp. HZA2.分离鉴定对乙酰氨基酚降解菌 sp. HZA2。
J Environ Sci Health B. 2022;57(5):333-338. doi: 10.1080/03601234.2022.2054247. Epub 2022 Mar 22.
10
Pharmaceutical pollution of the world's rivers.世界河流的药物污染。
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8). doi: 10.1073/pnas.2113947119.
Zotero 插件